@article{article, keywords = {Neglected Tropical Diseases, control, elimination, foreign assistance funding, mass drug administration}, author = {Wainwright E and Evans D and Rotondo L and Pou B and Yevstigneyeva V and Zoerhoff K and Ottesen E and Reithinger R}, title = {The Elimination of Neglected Tropical Diseases (NTDs): A Case Study Exemplifying How Foreign Assistance Funding Can Be Catalytic in Reducing the Burden of Major Global Health Conditions.}, abstract = {

In 2006, following direct advocacy and published rationale, the U.S. Agency for International Development (USAID) established a neglected tropical disease (NTD) program to support the scale-up of integrated platforms targeting the elimination and control of five NTDs-lymphatic filariasis, trachoma, onchocerciasis, schistosomiasis and soil-transmitted helminthiasis. By 2017, a cumulative total of over 2.3 billion NTD treatments had been delivered to at-risk populations in 25 countries, leveraging $19 billion in donated drugs - approximately $26 dollars in donated medicine per $1 spent by USAID. As a result, most of the supported countries are on track to achieve their elimination goals (for lymphatic filariasis and trachoma) by 2020 or 2021 and their control goals soon thereafter. Though {\textquoteright}small{\textquoteright} when compared to other global health initiatives, this investment proved to be catalytic-and indeed highlights how foreign assistance funding can be transformative-for reducing the burden of major global health conditions such as NTDs.

}, year = {2019}, journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, month = {08/2019}, issn = {1537-6591}, url = {https://academic.oup.com/cid/article-pdf/70/5/958/32450066/ciz742.pdf}, doi = {10.1093/cid/ciz742}, language = {eng}, }